Cairo, Egypt, 11 August 2025 — MicroPort NeuroScientific is pleased to announce the successful launch of NUMEN™ Coil Embolization System (NUMEN™) in Egypt, in partnership with PentaMed.
The first case, a complex large ACOM aneurysm, was successfully performed at Neurospitalia Hospital by Prof. Farouk Hassan. Seven Numen™ coils were deployed with Y-stenting, achieving complete aneurysm occlusion and deliver favorable clinical outcome.
Available in 177 specifications, Numen™ features ultra-fine platinum–tungsten wire and a distinctive three-dimensional structure that combines flexibility with optimal support. The design reduces pressure on the aneurysm wall and accommodates a wide variety of aneurysm morphologies.
This launch marks an exciting step forward as MicroPort NeuroScientific continues expanding access to innovative neurovascular solutions across this region. To date, NUMEN™ is commercially available in over 30 countries and regions worldwide.
About MicroPort NeuroScientific
MicroPort NeuroScientific (MicroPort NeuroScientific Corporation; HKEX: 2172), an associated company of MicroPort® (MicroPort Scientific Corporation; HKEX: 00853), is committed to the research and development of high-end medical devices in the field of neurological interventional treatment with solutions that currently support over 120 cerebrovascular stenting procedures every day. In the future, MicroPort NeuroScientific will continue investing more resources in innovation and development to provide more high-quality and innovative cerebrovascular and neuro-interventional solutions for physicians and patients.
More information is available at: https://www.microportneurosci.com/